https://www.taxtmi.com/news?id=73932 Generic medicine imports into the United States are proposed to remain duty-free for two years, followed by escalating tariffs. The structure is intended to encourage pharmaceutical companies to establish manufacturing plants and equipment in the United States, with higher duties applying where companies do not do so within the stated period. The policy is confined to generic drugs, while the approach for patented, branded and innovative medicines is stated to remain unchanged. en-us Wed, 22 Jul 2026 11:01:03 +0530 Wed, 22 Jul 2026 11:01:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=73932 Generic medicine imports into the United States are proposed to remain duty-free for two years, followed by escalating tariffs. The structure is intended to encourage pharmaceutical companies to establish manufacturing plants and equipment in the United States, with higher duties applying where companies do not do so within the stated period. The policy is confined to generic drugs, while the approach for patented, branded and innovative medicines is stated to remain unchanged. News - Wed, 22 Jul 2026 11:01:03 +0530 https://www.taxtmi.com/news?id=73932